Indeed, A375-M6 melanoma cells are BRAF mutated (V600E) and when they are adapted to an acidic medium they acquire an enhanced activation of PI-3 kinase-AKT pathway crucial for vemurafenib resistance development, as we have previously demonstrated [23]. This evidence concerns the gene AKT1 and melanoma.